Hepatocellular carcinoma (HCC) is one of the most common malignancy tumors with
insidious onset, rapid development and metastasis, and poor prognosis. Therefore, it is …

Background Recently, some studies have found that retinoblastoma-binding protein 2
(RBP2) is involved in the development and progression of many kinds of malignant tumors …

Background Retinoblastoma binding protein 4 (RBBP4) plays an essential role in the
development of multiple cancers. However, its relationship with prognosis in colon cancer …

Purpose Acyclic retinoid (ACR) has been shown to be a promising chemopreventive agent
for hepatocellular carcinoma (HCC) after curative resection. The effects of retinoid are …

Lung cancer is the most common cause of cancer-associated mortality in China with 85% of
patients having non-small cell lung cancer (NSCLC). Identifying NSCLC driver genes and …

Backgrounds. Retinol-binding protein 4 (RBP4) is a monomeric-binding protein belonging to
the lipocalin protein family, which has been reported to be dysregulated in several …

Background The prognosis of hepatocellular carcinoma (HCC) is universally poor. Early
diagnosis plays a pivotal role in determining the outcome of HCC. Methods We employed a …

Retinoblastoma binding protein 6 (RBBP6) plays an important role in chaperone-mediated
ubiquitination and interacts with TP53 in carcinogenesis. However, the clinicopathologic …

Previous studies have shown that retinoblastoma binding protein 6 (RBBP6) was
overexpressed in malignant tumors and was correlated with poorer prognosis in various …

Abstract Retinoblastoma‑binding protein 7 (RBBP7) is an important component of several
complexes that regulate chromatin metabolism. It is overexpressed in certain cancer types …